Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial GlobeNewswire August 11, 2025 TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company“), a biopharmaceutical […]

NEW YORK, NY / ACCESS Newswire / August 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has

(TSX:LABS),(OTC US:MEDIF),(Other OTC:MEDIF),(Boerse Frankfurt – Freiverkehr:MLZ), TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial results for the three and six months ended June

NEW YORK, NY / ACCESS Newswire / August 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of MediaAlpha, Inc. ("MediaAlpha") (NYSE:MAX) concerning possible violations of federal securities laws. On November 4, 2024, MediaAlpha disclosed receipt of a letter from the FTC, which stated that the FTC was "prepared to

MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results GlobeNewswire August 11, 2025 TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial

Hong Kong Baptist University (HKBU), Hong Kong Ballet (HKB) and Studio Wayne McGregor (SWM) proudly present the avant-garde choreographic installation Wayne McGregor: On The Other Earth, which had its world premiere as part of Biennale Danza, the 19th International Festival of Contemporary Dance of La Biennale di Venezia from 25 July to 2 August 2025

NEW YORK, NY / ACCESS Newswire / August 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Snap Inc. ("Snap Inc.") (NYSE:SNAP) concerning possible violations of federal securities laws. Investors.com reported on August 6, 2025, that "Snap . . . stock tumbled Wednesday after the Snapchat parent company posted

The Skywork AI Technology Release Week officially kicked off on August 11. From August 11 to August 15, a new model will be unveiled each day, covering cutting-edge models for multimodal AI scenarios. On August 11, Skywork officially launched the SkyReels-A3 model. Combining a Diffusion Transformer (DiT) model, frame interpolation for extended video generation, reinforcement

NEW YORK, NY / ACCESS Newswire / August 11, 2025 / If you suffered a loss on your Alto Neuroscience, Inc. (NYSE:ANRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alto-neuroscience-inc-lawsuit-submission-form?prid=160750&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / August 11, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=160751&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or